Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease.
FDA approves BMS’ Opdivo for urothelial carcinoma treatment
Share this article BMS’ Opdivo is indicated for use along with a chemotherapy regimen comprising cisplatin and gemcitabine. Credit: JHVEPhoto / Shutterstock.com. The US Food